Saint-Herblain (France), January 15, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company focused on prevention against diseases with major unmet needs, today announced an amendment to the terms of its existing debt facility with US-based healthcare investment firms Deerfield Management Company and OrbiMed.

Read the rest here:
Valneva Announces Amendment to Deerfield and OrbiMed Debt Facility Terms

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *